vs
Side-by-side financial comparison of Hour Loop, Inc (HOUR) and ARS Pharmaceuticals, Inc. (SPRY). Click either name above to swap in a different company.
Hour Loop, Inc is the larger business by last-quarter revenue ($56.1M vs $28.1M, roughly 2.0× ARS Pharmaceuticals, Inc.). Hour Loop, Inc runs the higher net margin — -1.2% vs -147.1%, a 146.0% gap on every dollar of revenue. On growth, Hour Loop, Inc posted the faster year-over-year revenue change (3.0% vs -67.6%).
Hour Loop, Inc. is an e-commerce retail company that offers a diverse portfolio of products including home goods, apparel, toys, electronics accessories, and daily consumer essentials. It primarily operates through leading third-party online marketplaces, with its core customer base concentrated in North America, focusing on delivering affordable, high-value daily products to mass consumers.
ARS Pharmaceuticals, Inc. is a late-stage biopharmaceutical firm specializing in the development and commercialization of novel therapies for severe allergic reactions, most notably needle-free epinephrine delivery solutions for anaphylaxis. It primarily operates in the North American market, catering to both pediatric and adult patient groups at risk of life-threatening allergic responses.
HOUR vs SPRY — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $56.1M | $28.1M |
| Net Profit | $-657.3K | $-41.3M |
| Gross Margin | 49.6% | — |
| Operating Margin | -1.5% | -147.6% |
| Net Margin | -1.2% | -147.1% |
| Revenue YoY | 3.0% | -67.6% |
| Net Profit YoY | 57.0% | -182.8% |
| EPS (diluted) | $-0.02 | $-0.41 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $56.1M | $28.1M | ||
| Q3 25 | $33.4M | $32.5M | ||
| Q2 25 | $27.1M | $15.7M | ||
| Q1 25 | $25.8M | $8.0M | ||
| Q4 24 | $54.4M | $86.6M | ||
| Q3 24 | $31.1M | $2.1M | ||
| Q2 24 | $28.1M | $500.0K | ||
| Q1 24 | $24.7M | $0 |
| Q4 25 | $-657.3K | $-41.3M | ||
| Q3 25 | $530.6K | $-51.2M | ||
| Q2 25 | $1.2M | $-44.9M | ||
| Q1 25 | $654.5K | $-33.9M | ||
| Q4 24 | $-1.5M | $49.9M | ||
| Q3 24 | $469.6K | $-19.1M | ||
| Q2 24 | $649.1K | $-12.5M | ||
| Q1 24 | $1.1M | $-10.3M |
| Q4 25 | 49.6% | — | ||
| Q3 25 | 51.4% | — | ||
| Q2 25 | 57.2% | — | ||
| Q1 25 | 54.7% | — | ||
| Q4 24 | 45.7% | — | ||
| Q3 24 | 54.8% | — | ||
| Q2 24 | 55.7% | — | ||
| Q1 24 | 58.6% | — |
| Q4 25 | -1.5% | -147.6% | ||
| Q3 25 | 2.2% | -163.7% | ||
| Q2 25 | 6.0% | -302.9% | ||
| Q1 25 | 3.6% | -466.3% | ||
| Q4 24 | -4.5% | 54.5% | ||
| Q3 24 | 2.3% | -1051.6% | ||
| Q2 24 | 3.3% | -3068.0% | ||
| Q1 24 | 6.2% | — |
| Q4 25 | -1.2% | -147.1% | ||
| Q3 25 | 1.6% | -157.4% | ||
| Q2 25 | 4.3% | -285.6% | ||
| Q1 25 | 2.5% | -425.7% | ||
| Q4 24 | -2.8% | 57.7% | ||
| Q3 24 | 1.5% | -925.0% | ||
| Q2 24 | 2.3% | -2503.2% | ||
| Q1 24 | 4.3% | — |
| Q4 25 | $-0.02 | $-0.41 | ||
| Q3 25 | $0.01 | $-0.52 | ||
| Q2 25 | $0.04 | $-0.46 | ||
| Q1 25 | $0.02 | $-0.35 | ||
| Q4 24 | $-0.04 | $0.52 | ||
| Q3 24 | $0.01 | $-0.20 | ||
| Q2 24 | $0.02 | $-0.13 | ||
| Q1 24 | $0.03 | $-0.11 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $245.0M |
| Total DebtLower is stronger | — | $96.4M |
| Stockholders' EquityBook value | $7.0M | $114.3M |
| Total Assets | $23.8M | $327.7M |
| Debt / EquityLower = less leverage | — | 0.84× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $245.0M | ||
| Q3 25 | — | $288.2M | ||
| Q2 25 | — | $240.1M | ||
| Q1 25 | — | $275.7M | ||
| Q4 24 | — | $314.0M | ||
| Q3 24 | — | $204.6M | ||
| Q2 24 | — | $218.7M | ||
| Q1 24 | $2.9M | $223.6M |
| Q4 25 | — | $96.4M | ||
| Q3 25 | — | $96.2M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $0 | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $7.0M | $114.3M | ||
| Q3 25 | $7.7M | $147.7M | ||
| Q2 25 | $7.2M | $192.3M | ||
| Q1 25 | $5.8M | $229.0M | ||
| Q4 24 | $5.2M | $256.8M | ||
| Q3 24 | $6.7M | $201.0M | ||
| Q2 24 | $6.2M | $215.2M | ||
| Q1 24 | $5.5M | $223.9M |
| Q4 25 | $23.8M | $327.7M | ||
| Q3 25 | $31.6M | $372.8M | ||
| Q2 25 | $23.0M | $313.5M | ||
| Q1 25 | $19.1M | $327.3M | ||
| Q4 24 | $20.0M | $351.2M | ||
| Q3 24 | $32.4M | $217.6M | ||
| Q2 24 | $20.2M | $222.0M | ||
| Q1 24 | $16.7M | $227.6M |
| Q4 25 | — | 0.84× | ||
| Q3 25 | — | 0.65× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $3.0M | $-43.5M |
| Free Cash FlowOCF − Capex | $3.0M | — |
| FCF MarginFCF / Revenue | 5.3% | — |
| Capex IntensityCapex / Revenue | 0.0% | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $2.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.0M | $-43.5M | ||
| Q3 25 | $500.4K | $-47.0M | ||
| Q2 25 | $-901.5K | $-39.6M | ||
| Q1 25 | $-23.9K | $-40.7M | ||
| Q4 24 | $1.5M | $42.0M | ||
| Q3 24 | $-2.2M | $-14.5M | ||
| Q2 24 | $456.2K | $-7.3M | ||
| Q1 24 | $492.9K | $-6.7M |
| Q4 25 | $3.0M | — | ||
| Q3 25 | $449.3K | $-47.2M | ||
| Q2 25 | $-901.6K | $-39.6M | ||
| Q1 25 | $-24.6K | $-40.8M | ||
| Q4 24 | $1.5M | $41.7M | ||
| Q3 24 | $-2.2M | $-14.6M | ||
| Q2 24 | $439.4K | $-7.3M | ||
| Q1 24 | $475.1K | $-6.8M |
| Q4 25 | 5.3% | — | ||
| Q3 25 | 1.3% | -145.4% | ||
| Q2 25 | -3.3% | -252.2% | ||
| Q1 25 | -0.1% | -512.1% | ||
| Q4 24 | 2.8% | 48.2% | ||
| Q3 24 | -7.0% | -706.3% | ||
| Q2 24 | 1.6% | -1463.4% | ||
| Q1 24 | 1.9% | — |
| Q4 25 | 0.0% | 0.0% | ||
| Q3 25 | 0.2% | 0.6% | ||
| Q2 25 | 0.0% | 0.3% | ||
| Q1 25 | 0.0% | 1.1% | ||
| Q4 24 | 0.0% | 0.3% | ||
| Q3 24 | 0.0% | 6.8% | ||
| Q2 24 | 0.1% | 7.6% | ||
| Q1 24 | 0.1% | — |
| Q4 25 | — | — | ||
| Q3 25 | 0.94× | — | ||
| Q2 25 | -0.77× | — | ||
| Q1 25 | -0.04× | — | ||
| Q4 24 | — | 0.84× | ||
| Q3 24 | -4.64× | — | ||
| Q2 24 | 0.70× | — | ||
| Q1 24 | 0.46× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
HOUR
Segment breakdown not available.
SPRY
| Products | $20.3M | 72% |
| Other | $7.8M | 28% |
